These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2186323)

  • 1. Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for Chemotherapy.
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Adam D
    Onkologie; 1990 Feb; 13(1):38-42. PubMed ID: 2186323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
    Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.
    Link H; Maschmeyer G; Meyer P; Hiddemann W; Stille W; Helmerking M; Adam D
    Ann Hematol; 1994 Nov; 69(5):231-43. PubMed ID: 7948312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study.
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
    Cancer; 1994 May; 73(9):2296-304. PubMed ID: 8168033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
    Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.
    Schiel X; Link H; Maschmeyer G; Glass B; Cornely OA; Buchheidt D; Wilhelm M; Silling G; Helmerking M; Hiddemann W; Ostermann H; Hentrich M
    Infection; 2006 Jun; 34(3):118-26. PubMed ID: 16804654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of antibiotic therapy in fever of unknown origin in neutropenic cancer patients.
    Björnsson S; Preisler H; Henderson ES
    Med Pediatr Oncol; 1977; 3(4):379-85. PubMed ID: 337094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem/cilastatin as initial therapy for febrile neutropenic patients.
    Liang R; Yung R; Chau PY; Chan TK; Lam WK; So SY; Todd D
    J Antimicrob Chemother; 1988 Nov; 22(5):765-70. PubMed ID: 3209533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventional antimicrobial therapy in febrile neutropenic patients.
    Maschmeyer G
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):205-12. PubMed ID: 10403100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response rates to a staged antibiotic regimen in febrile neutropenic patients.
    Barnes RA; Rogers TR
    J Antimicrob Chemother; 1988 Nov; 22(5):759-63. PubMed ID: 3209532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imipenem/cilastatin as monotherapy in neutropenic patients with fever].
    Fridrik MA; Wahl G; Grafinger-Witt E; Leisch F
    Wien Med Wochenschr; 1988 Nov; 138(21):548-51. PubMed ID: 3201783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Empiric therapy with aztreonam for febrile neutropenic patients with hematological malignancies].
    Moriuchi Y; Soda H; Toriya K; Tomonaga M; Ichimaru M
    Kansenshogaku Zasshi; 1989 Sep; 63(9):1022-5. PubMed ID: 2509590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
    Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
    Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
    Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital.
    Bodey GP
    Rev Infect Dis; 1989; 11 Suppl 7():S1582-90. PubMed ID: 2690296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.